Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | FDPS | P14324 | 1/20 | 0.36 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28343151 | 0.97 | CHRM1 (0.36) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL2517912 | 0.97 | CHRM1 (0.36) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL16163212 | 0.90 | FDPS (0.43) | TSHRFDPS | |
| SCHEMBL940772 | 0.89 | — | — | |
| SCHEMBL25405199 | 0.88 | FDPS (0.41) | TSHRFDPS | |
| SCHEMBL16163021 | 0.88 | FDPS (0.45) | FDPSLMNA | |
| SCHEMBL29120177 | 0.87 | LMNA (0.34) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL4772203 | 0.87 | LMNA (0.34) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL28120332 | 0.87 | LMNA (0.34) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL28086698 | 0.87 | LMNA (0.34) | CHRM1AKR1A1CHRM3HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112778359-B | Dialkyl phosphinate and preparation method and application thereof | 浙江新化化工股份有限公司 | 2022-09-16 | — | — | CN | claimed |
| CN-112778359-A | Dialkyl phosphinate and preparation method and application thereof | 浙江新化化工股份有限公司 | 2021-05-11 | — | — | CN | claimed |
| EP-2794623-B1 | MIXTURES OF AT LEAST ONE DIALKYLPHOSPHINIC ACID WITH AT LEAST ONE OTHER DIALKYLPHOSPHINIC ACID THAT IS DIFFERENT THEREFROM, METHOD FOR PRODUCTION THEREOF, AND USE THEREOF | CLARIANT INT LTD (CH) | 2017-10-18 | — | — | EP | claimed |
| EP-2791151-B1 | MIXTURES OF DIALKYLPHOSPHINIC ACIDS AND ALKYLPHOSPHONIC ACIDS, A PROCESS FOR PREPARATION THEREOF AND USE THEREOF | CLARIANT INT LTD (CH) | 2016-09-07 | — | — | EP | claimed |
| US-20140350149-A1 | Mixtures Of At Least One Dialkylphosphinic Acid With At Least One Other Dialkylphosphinic Acid That Is Different Therefrom, Method For Production Thereof, And Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2014-11-27 | — | — | US | claimed |
| US-20140309340-A1 | Mixtures Of Dialkylphosphinic Acids And Alkylphosphinic Acids, A Process For Preparation Thereof And Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2014-10-16 | — | — | US | claimed |
| CN-118562063-A | Liquid composition comprising a phosphorus-based additive, use thereof and material or composition obtained after polymerization of the composition | 阿肯马法国公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-116745025-A | membrane for water filtration | 水通道蛋白有限公司 | 2023-09-12 | — | — | CN | disclosed |
| US-11629212-B2 | Liquid composition comprising a phousphorus based additive, its use and material or composition obtained following polymerisation of composition | ARKEMA FRANCE (FR) | 2023-04-18 | — | — | US | disclosed |
| CN-112778359-B | Dialkyl phosphinate and preparation method and application thereof | 浙江新化化工股份有限公司 | 2022-09-16 | — | — | CN | disclosed |
| CN-112778359-A | Dialkyl phosphinate and preparation method and application thereof | 浙江新化化工股份有限公司 | 2021-05-11 | — | — | CN | disclosed |
| EP-3744743-A1 | LIQUID COMPOSITION COMPRISING A PHOSPHORUS BASED ADDITIVE, ITS USE AND MATERIAL OR COMPOSITION OBTAINED FOLLOWING POLYMERISATION OF COMPOSTION | ARKEMA FRANCE (FR) | 2020-12-02 | — | — | EP | disclosed |
| EP-3481875-B1 | LIQUID COMPOSITION COMPRISING A PHOUSPHORUS BASED ADDITIVE, ITS USE AND MATERIAL OR COMPOSITION OBTAINED FOLLOWING POLYMERISATION OF COMPOSITION | ARKEMA FRANCE (FR) | 2020-04-08 | — | — | EP | disclosed |
| US-10246640-B2 | Mixtures of at least one dialkylphosphinic acid with at least one other dialkylphosphinic acid that is different therefrom, method for production thereof, and use thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2019-04-02 | — | — | US | disclosed |
| US-10106744-B2 | Mixtures of dialkylphosphinic acids and alkylphosphinic acids, a process for preparation thereof and use thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2018-10-23 | — | — | US | disclosed |
| WO-2018011193-A1 | LIQUID COMPOSITION COMPRISING A PHOUSPHORUS BASED ADDITIVE, ITS USE AND MATERIAL OR COMPOSITION OBTAINED FOLLOWING POLYMERISATION OF COMPOSTION | ARKEMA FRANCE (FR) | 2018-01-18 | — | — | WO | disclosed |
| US-20180010047-A1 | Mixtures Of At Least One Dialkylphosphinic Acid With At Least One Other Dialkylphosphinic Acid That Is Different Therefrom, Method For Production Thereof, And Use Thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2018-01-11 | — | — | US | disclosed |
| US-20140350149-A1 | Mixtures Of At Least One Dialkylphosphinic Acid With At Least One Other Dialkylphosphinic Acid That Is Different Therefrom, Method For Production Thereof, And Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2014-11-27 | — | — | US | disclosed |
| US-20140309340-A1 | Mixtures Of Dialkylphosphinic Acids And Alkylphosphinic Acids, A Process For Preparation Thereof And Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2014-10-16 | — | — | US | disclosed |
| US-20110245386-A1 | Method for the Production of Mixed-Substituted Dialkylphosphinic Acids, Esters, and Salts, and Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10106744-B2 | Mixtures of dialkylphosphinic acids and alkylphosphinic acids, a process for preparation thereof and use thereof | C3AR1, ENPP2, AKR1C3 | CHRM1 998/4885AKR1A1 68/4885CHRM3 1448/4885 |
| US-10246640-B2 | Mixtures of at least one dialkylphosphinic acid with at least one other dialkylphosphinic acid that is different therefrom, method for production thereof, and use thereof | CYP27A1, CYP21A2, CYP46A1 | CHRM1 775/4885AKR1A1 27/4885CHRM3 1123/4885 |
| US-20180010047-A1 | Mixtures Of At Least One Dialkylphosphinic Acid With At Least One Other Dialkylphosphinic Acid That Is Different Therefrom, Method For Production Thereof, And Use Thereof | CYP21A2, CYP27A1, CYP46A1 | CHRM1 490/4885AKR1A1 24/4885CHRM3 690/4885 |
| US-20110245386-A1 | Method for the Production of Mixed-Substituted Dialkylphosphinic Acids, Esters, and Salts, and Use Thereof | HAO2, ACSL3, SCO2 | CHRM1 1167/4885AKR1A1 381/4885CHRM3 1823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.